Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasis.
Birnbaum MD, Zhao N, Moorthy BT, Patel DM, Kryvenko ON, Heidman L, Kumar A, Morgan WM, Ban Y, Reis IM, Chen X, Gonzalgo ML, Jorda M, Burnstein KL, Zhang F.
Birnbaum MD, et al.
Oncogene. 2019 Feb;38(6):838-851. doi: 10.1038/s41388-018-0462-2. Epub 2018 Sep 3.
Oncogene. 2019.
PMID: 30177837
Free PMC article.